CenterWatch Weekly
May 18, 2009 by admin
Filed under Media Reports, Media Reports 2009
Novotech in Joint Venture with Indian CRO, Focuses on Asian Expansion In keeping with its strategic focus on expanding in Asia, Australia-based contract research organization (CRO) Novotech has entered into a joint venture with ETI Klinical, a CRO based in Bangalore, India, and part of the Karle Group. Novotech already had, and will keep, its [...]
Applied Clinical Trials
May 6, 2009 by admin
Filed under Media Reports, Media Reports 2009
Novotech Signs Joint Venture with Indian CRO ETI Klinical Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $600 million Indian multinational. The joint venture designed to service the growing demand for global [...]
FierceBiotech
May 6, 2009 by admin
Filed under Media Reports, Media Reports 2009
Novotech signs joint venture with Indian CRO ETI Klinical PVT Limited deal to drive more global clinical trials to India Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $ 600 million Indian [...]
PharmAsia News
May 6, 2009 by admin
Filed under Media Reports, Media Reports 2009
Aussie CRO Novotech Expands Asian Footprint With Indian ETI Joint Venture: An Interview With PharmAsia News The largest independent research organization in Australia, Sydney-based Novotech announced May 6 that it formed a joint venture with Bangalore-based ETI Klinical, which is part of the multinational Karle Group. With operations in Australia, New Zealand, the United States, [...]
Genetic Engineering News
May 6, 2009 by admin
Filed under Media Reports, Media Reports 2009
Novotech and ETI Ally to Harness Indian Clinical Research Opportunities Australia-based CRO, Novotech, and Indian CRO, ETI Klinical, are teaming up to help meet the growing international demand for clinical research in India. The joint venture aims to cover a wide range of therapeutic areas including oncology, respiratory disorders, infectious diseases, psychiatry, metabolic disorders, devices, [...]
Australian Financial Review
March 10, 2009 by admin
Filed under Media Reports, Media Reports 2009
Biotechs face bloodbath The listed Australian biotechnology sector expects a bloodbath, with industry heavyweights saying the struggles demonstrated by many smaller biotech stocks in February reporting season will leave many unsustainable by the end of the year. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1034
